StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by Jonnyboy85on Dec 16, 2020 12:01pm

112 Views

Post# 32119034

Told you the shorts would be at it

They buy back their shorts leading up to the 15th and EOM, then start bashing like they did yesterday and today, and on the16th and the 1st they short again, this effectively hides their activity because the short report doesn't show individual transactions, only the net difference in shorting totals. I sure hope you don't fall for their game.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024